Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro, Santa Mammana, Eugenio Cavalli, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1459-1459
Open Access | Times Cited: 219

Showing 51-75 of 219 citing articles:

Decoding epilepsy treatment: A comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations
Mohamed Osman, Jamileh Khalil, Mostafa El-Bahri, et al.
Chemico-Biological Interactions (2024) Vol. 394, pp. 110988-110988
Open Access | Times Cited: 3
Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC–MS-MS
Lin Lin, Piyadarsha Amaratunga, Jerome Reed, et al.
Journal of Analytical Toxicology (2020) Vol. 46, Iss. 1, pp. 76-88
Closed Access | Times Cited: 25
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23
Development of Water-Soluble Electrospun Fibers for the Oral Delivery of Cannabinoids
Eleftherios G. Andriotis, Konstantina Chachlioutaki, Paraskevi Kyriaki Monou, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 1
Closed Access | Times Cited: 21
Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
Gniewko Więckiewicz, Iga Stokłosa, Maciej Stokłosa, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 15
Heavy metal and phthalate contamination and labeling integrity in a large sample of US commercially available cannabidiol (CBD) products
Hannah Gardener, Chela Wallin, Jaclyn Bowen
The Science of The Total Environment (2022) Vol. 851, pp. 158110-158110
Closed Access | Times Cited: 14
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
Simon Erridge, Carl Holvey, Ross Coomber, et al.
Neuropediatrics (2022) Vol. 54, Iss. 03, pp. 174-181
Open Access | Times Cited: 14
The Antioxidant and Neuroprotective Potential of Leaves and Inflorescences Extracts of Selected Hemp Varieties Obtained with scCO2
Anna Stasiłowicz-Krzemień, Szymon Sip, Piotr Szulc, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1827-1827
Open Access | Times Cited: 8
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
Patrycja Bielawiec, Ewa Harasim‐Symbor, Karolina Konstantynowicz-Nowicka, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1241-1241
Open Access | Times Cited: 22
Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences
Anna Stasiłowicz-Krzemień, Piotr Szulc, Judyta Cielecka‐Piontek
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 7
Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy
Ana Paula de Araújo Boleti, Breno Emanuel Farias Frihling, Patrícia Souza e Silva, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 132, pp. 1214-1228
Closed Access | Times Cited: 20
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
Rafael Mariano de Bitencourt, Reinaldo Ν. Takahashi, E.A. Carlini
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16
Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 230-248
Closed Access | Times Cited: 16
The cannabidiol and marijuana research expansion act: Promotion of scientific knowledge to prevent a national health crisis
John M. Purcell, Tija M. Passley, Joerg R. Leheste
The Lancet Regional Health - Americas (2022) Vol. 14, pp. 100325-100325
Open Access | Times Cited: 11
Morphological and genetic analysis of inflorescence and flower development in hemp (Cannabis sativaL.)
Jiaqi Shi, Susanne Schilling, Rainer Melzer
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
Kennadi Johnson, Abby J. Weldon, Melissa A. Burmeister
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
Shareen Singh, Thakur Gurjeet Singh, Ashish K. Rehni
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 10, pp. 750-779
Closed Access | Times Cited: 18
Do E-cigarettes and vaping have a lower risk of osteoporosis, nonunion, and infection than tobacco smoking?
Thomas Nicholson, Aaron Scott, Matthew Newton Ede, et al.
Bone and Joint Research (2021) Vol. 10, Iss. 3, pp. 188-191
Open Access | Times Cited: 15
Analysis of YouTube videos as a source of information for reliability and effectiveness of cannabidiol oil in treatment of epilepsy
Hakan Şilek, Özgür Bilgin Topçuoğlu
Epilepsy & Behavior (2022) Vol. 138, pp. 109017-109017
Closed Access | Times Cited: 10
Process Intensification for Obtaining a Cannabidiol Intermediate by Photo-oxygenation of Limonene under Continuous-Flow Conditions
Anderson R. Aguillón, Raquel A. C. Leão, Kléber T. de Oliveira, et al.
Organic Process Research & Development (2020) Vol. 24, Iss. 10, pp. 2017-2024
Closed Access | Times Cited: 16
Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy
L. Hay
South African Medical Journal (2020) Vol. 110, Iss. 2, pp. 102-102
Open Access | Times Cited: 15
A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System
Yin-Sir Chung, Brandon Kar Meng Choo, Pervaiz K. Ahmed, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 15
Cannabidiol Discovery and Synthesis—a Target‐Oriented Analysis in Drug Production Processes
Anderson R. Aguillón, Raquel A. C. Leão, Leandro S. M. Miranda, et al.
Chemistry - A European Journal (2020) Vol. 27, Iss. 18, pp. 5577-5600
Closed Access | Times Cited: 15
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology
Sônia Maria Dozzi Brucki, Tarso Adoni, Carlos Maurício Oliveira de Almeida, et al.
Arquivos de Neuro-Psiquiatria (2021) Vol. 79, Iss. 4, pp. 354-369
Open Access | Times Cited: 14

Scroll to top